Richard T. Timms

Richard T. Timms

Auto-generated profile, based on publicly available information

Richard T. Timms

Cambridge Institute of Therapeutic immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2020 in Science
Verified
Journal Article
Open access
PDF file
ESEllen Shrock
Ellen Shrock
EFEric Fujimura
Eric Fujimura
TKTomasz Kula
Tomasz Kula
RTRichard T. Timms
Richard T. Timms
ILI-Hsiu Lee
I-Hsiu Lee
SEStephen J. Elledge
Stephen J. Elledge
Profiling coronaviruses: Among the coronaviruses that infect humans, four cause mild common colds, whereas three others, including the currently circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), result in severe infections. Shrock et al. used a technology known as VirScan to probe the antibody repertoires of hundreds of coronavirus disease 2019 (COVID-19) patients and pre–COVID-19 era controls. They identified hundreds of antibody targets, including several antibody epitopes shared by the mild and severe coronaviruses and many specific to SARS-CoV-2. A machine-learning model accurately classified patients infected with SARS-CoV-2 and guided the design of an assay for rapid SARS-CoV-2 antibody detection. The study also looked at how the antibody response and viral exposure history differ in patients with diverging outcomes, which could inform the production of improved vaccine and antibody therapies. Science , this issue p. eabd4250

5 July 2019 in Science
Verified
Journal Article
Closed access
PDF file
RTRichard T. Timms
Richard T. Timms
ZZZhiqian Zhang
Zhiqian Zhang
DRDavid Y. Rhee
David Y. Rhee
JHJ. Wade Harper
J. Wade Harper
IKItay Koren
Itay Koren
SEStephen J. Elledge
Stephen J. Elledge
Glycine N-degron regulation revealed: For more than 30 years, N-terminal sequences have been known to influence protein stability, but additional features of these N-end rule, or N-degron, pathways continue to be uncovered. Timms et al. used a global protein stability (GPS) technology to take a broader look at these pathways in human cells. Unexpectedly, glycine exposed at the N terminus could act as a potent degron; proteins bearing N-terminal glycine were targeted for proteasomal degradation by two Cullin-RING E3 ubiquitin ligases through the substrate adaptors ZYG11B and ZER1. This pathway may be important, for example, to degrade proteins that fail to localize properly to cellular membranes and to destroy protein fragments generated during cell death. Science , this issue p. eaaw4912

6 July 2020 in Biochemical Society Transactions
Verified
Journal Article
Open access
PDF file
RTRichard T. Timms
Richard T. Timms
IKItay Koren
Itay Koren
Selective protein degradation by the ubiquitin-proteasome system (UPS) is thought to be governed primarily by the recognition of specific motifs — degrons — present in substrate proteins. The ends of proteins — the N- and C-termini – have unique properties, and an important subset of protein–protein interactions involve the recognition of free termini. The first degrons to be discovered were located at the extreme N-terminus of proteins, a finding which initiated the study of the N-degron (formerly N-end rule) pathways, but only in the last few years has it emerged that a diverse set of C-degron pathways target analogous degron motifs located at the extreme C-terminus of proteins. In this minireview we summarise the N-degron and C-degron pathways currently known to operate in human cells, focussing primarily on those that have been discovered in recent years. In each case we describe the cellular machinery responsible for terminal degron recognition, and then consider some of the functional roles of terminal degron pathways. Altogether, a broad spectrum of E3 ubiquitin ligases mediate the recognition of a diverse array of terminal degron motifs; these degradative pathways have the potential to influence a wide variety of cellular functions.

2 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CDChristopher H. Douse
Christopher H. Douse
ITIva A. Tchasovnikarova
Iva A. Tchasovnikarova
RTRichard T. Timms
Richard T. Timms
APAnna V. Protasio
Anna V. Protasio
MSMarta Seczynska
Marta Seczynska
YMYorgo Modis
Yorgo Modis
The HUSH complex represses retroviruses, transposons and genes to maintain the integrity of vertebrate genomes. HUSH regulates deposition of the epigenetic mark H3K9me3, but how its three core subunits — TASOR, MPP8 and Periphilin — contribute to assembly and targeting of the complex remains unknown. Here, we define the biochemical basis of HUSH assembly and find that its modular architecture resembles the yeast RNA-induced transcriptional silencing complex. TASOR, the central HUSH subunit, associates with RNA processing components. TASOR is required for H3K9me3 deposition over LINE-1 repeats and repetitive exons in transcribed genes. In the context of previous studies, this suggests that an RNA intermediate is important for HUSH activity. We dissect the TASOR and MPP8 domains necessary for transgene repression. Structure-function analyses reveal TASOR bears a catalytically-inactive PARP domain necessary for targeted H3K9me3 deposition. We conclude that TASOR is a multifunctional pseudo-PARP that directs HUSH assembly and epigenetic regulation of repetitive genomic targets.

7 April 2023 in Science
Verified
Journal Article
Open access
ESEllen L. Shrock
Ellen L. Shrock
RTRichard T. Timms
Richard T. Timms
TKTomasz Kula
Tomasz Kula
EMElijah L. Mena
Elijah L. Mena
AWAnthony P. West
Anthony P. West
SEStephen J. Elledge
Stephen J. Elledge
Despite the vast diversity of the antibody repertoire, infected individuals often mount antibody responses to precisely the same epitopes within antigens. The immunological mechanisms underpinning this phenomenon remain unknown. By mapping 376 immunodominant “public epitopes” at high resolution and characterizing several of their cognate antibodies, we concluded that germline-encoded sequences in antibodies drive recurrent recognition. Systematic analysis of antibody-antigen structures uncovered 18 human and 21 partially overlapping mouse germline-encoded amino acid–binding (GRAB) motifs within heavy and light V gene segments that in case studies proved critical for public epitope recognition. GRAB motifs represent a fundamental component of the immune system’s architecture that promotes recognition of pathogens and leads to species-specific public antibody responses that can exert selective pressure on pathogens.

21 September 2023 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
RTRichard T. Timms
Richard T. Timms
EMElijah L. Mena
Elijah L. Mena
YLYumei Leng
Yumei Leng
MLMamie Z. Li
Mamie Z. Li
ITIva A. Tchasovnikarova
Iva A. Tchasovnikarova
SEStephen J. Elledge
Stephen J. Elledge
Specificity within the ubiquitin–proteasome system is primarily achieved through E3 ubiquitin ligases, but for many E3s their substrates—and in particular the molecular features (degrons) that they recognize—remain largely unknown. Current approaches for assigning E3s to their cognate substrates are tedious and low throughput. Here we developed a multiplex CRISPR screening platform to assign E3 ligases to their cognate substrates at scale. A proof-of-principle multiplex screen successfully performed ~100 CRISPR screens in a single experiment, refining known C-degron pathways and identifying an additional pathway through which Cul2FEM1B targets C-terminal proline. Further, by identifying substrates for Cul1FBXO38, Cul2APPBP2, Cul3GAN, Cul3KLHL8, Cul3KLHL9/13 and Cul3KLHL15, we demonstrate that the approach is compatible with pools of full-length protein substrates of varying stabilities and, when combined with site-saturation mutagenesis, can assign E3 ligases to their cognate degron motifs. Thus, multiplex CRISPR screening will accelerate our understanding of how specificity is achieved within the ubiquitin–proteasome system.